Switzerland· 44644045
Elotrans, Pulver zur Herstellung einer Lösung zum Einnehmen
A oral rehydration salt formulations product containing glucosum, natrii chloridum, kalii chloridum, natrii citras dihydricus, registered in Switzerland by Helvepharm AG and dispensed under Swissmedic category D, on the national reimbursement list. The same ATC class is registered in 5 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Glucosum, natrii chloridum, kalii chloridum, natrii citras dihydricus is registered in 5 of 19 countries.
Countries holding a registration under ATC A07CA (oral rehydration salt formulations), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 4 of them publish a price we can compare per daily dose
Glucosum, natrii chloridum, kalii chloridum, natrii citras dihydricus · ATC A07CA
5 / 19 countries
- Finlandprice
- Ireland
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- glucosum, natrii chloridum, kalii chloridum, natrii citras dihydricus
- Manufacturer
- Helvepharm AG
- Country
- Switzerland (CH)
- ATC code
- A07CA
- ATC class
- Oral rehydration salt formulations
- Swissmedic category
- D
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin768044644045020 Btl 6.03 gCHF 8.45
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Glucosum, natrii chloridum, kalii chloridum, natrii citras dihydricus in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Estonia · Rehydron Optim
- Spain · Sueroral Hiposódico
- Finland · Rehydron Optim
- Greece · Dextrolyte
- Lithuania · Rehydron Optim
- Latvia · Rehydron, Rehydron Optim
- Norway · Gem
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/da03857f-bada-4d57-8ef0-1c58ff7a57f2 GET /v1/drugs/da03857f-bada-4d57-8ef0-1c58ff7a57f2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "glucosum anhydricum 4 g + natrii chloridum 700 mg + kalii chloridum 300 mg + natrii citras dihydricus 590 mg",
"valid_from": "1984-03-15",
"limitations": null,
"galenic_form": "Plv",
"therapeutic_area": null,
"sl_inclusion_date": "1984-03-15",
"self_retention_pct": 10
}See everything about glucosum, natrii chloridum, kalii chloridum, natrii citras dihydricus.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.